Back to calendar
Fate Therapeutics, Inc. (FATE) Earnings
FATE reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.27
Actual EPS: $-0.25
EPS surprise: 1.43%
Company overview
Market Cap$286.4M
PriceUSD 2.39
EPS (TTM)-1.05
52-week high3.23
52-week low0.93
SectorHealth Technology
IndustryBiotechnology
Employees161